The onset of late severe lung impairment in COVID-19 is associated with high inflammation markers at admission and metabolic syndrome markers https://www.medrxiv.org/content/10.1101/2022.12.20.22282909
The onset of late severe lung impairment in COVID-19 is associated with high inflammation markers at admission and metabolic syndrome markers https://www.medrxiv.org/content/10.1101/2022.12.20.22282909